IGF1R and cancer: Insulin-like growth factor 1 receptor (IGF1R) is a transmembrane receptor tyrosine kinase (RTK) frequently found to be upregulated and associated with cancer progression and patients’ poor prognosis in multiple cancer types including HCC [13,14,15,16,17].